MA

Mayurkumar Arvindbhai Patel

Active Director Director DIN 08107924
DIN 08107924 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayurkumar Arvindbhai Patel

Data last updated:

Mayurkumar Arvindbhai Patel is a Director at Trovip Pharmaceuticals Private Limited (since 2018). The company operates in Pharma.

DIN 08107924
Primary Designation Director
Industry Pharma
First Appointment 11 Apr 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Apr 20182018Active

Directorship timeline

Open interactive timeline →
Trovip Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mayurkumar Arvindbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayurkumar Arvindbhai Patel

Mayurkumar Arvindbhai Patel currently holds 1 directorship: Trovip Pharmaceuticals Private Limited (Director, since 11 Apr 2018).

Mayurkumar Arvindbhai Patel was first appointed on 11 Apr 2018 as Director at Trovip Pharmaceuticals Private Limited.

The current boards of Mayurkumar Arvindbhai Patel's companies include Amitkumar Ashokbhai Patel (Trovip Pharmaceuticals Private Limited), Sunil Jagdishlal Brahamkhatri (Trovip Pharmaceuticals Private Limited), Tejas Rohitbhai Patel (Trovip Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available